Literature DB >> 3422154

Activation of phospholipase D by chemotactic peptide in HL-60 granulocytes.

J K Pai1, M I Siegel, R W Egan, M M Billah.   

Abstract

Activation of phospholipase D (PLD) has been investigated in dimethylsulfoxide differentiated HL-60 granulocytes labeled in endogenous 1-0-alkyl-2-acyl-sn-glycero-3-phosphocholine (alkyl-PC) by incubation with [3H]alkyl-lysoPC. Stimulation of these labeled cells with the chemotactic peptide, N-formyl-Met-Leu-Phe (fMLP), induces rapid generation of [3H]phosphatidic acid (PA) and slower formation of [3H]diglyceride, suggesting hydrolysis of alkyl-PC by PLD. A unique feature of PLD is its ability to transfer the phosphatidyl moiety of phospholipids to alcohols (transphosphatidylation). This characteristic has been exploited to identify PLD activity. For example, when ethanol is present during stimulation of the HL-60 cells, [3H]phosphatidylethanol (PEt) is formed with a concomitant decrease in [3H]PA. Cells incubated with [32P]orthophosphate to label the terminal phosphate of ATP do not incorporate 32P into PEt, consistent with the [3H]PEt not being synthesized from [3H]diglyceride. In contrast, [3H]PA arises from both PLD and diglyceride kinase activities. Furthermore, PEt synthesis closely parallels PA formation and both are inhibited by an fMLP receptor antagonist, suggesting that both PA and PEt are derived from agonist-stimulated PLD action. These observations are consistent with phospholipase D-catalyzed breakdown of alkyl-PC in fMLP- stimulated granulocytes.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3422154     DOI: 10.1016/0006-291x(88)90528-1

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  33 in total

Review 1.  The regulation and cellular functions of phosphatidylcholine hydrolysis.

Authors:  M M Billah; J C Anthes
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

2.  Platelet-derived growth factor activates phospholipase D and chemotactic responses in vascular smooth muscle cells.

Authors:  C J Welsh; K Schmeichel; K McBride
Journal:  In Vitro Cell Dev Biol       Date:  1991-05

3.  Poster communications.

Authors: 
Journal:  Br J Pharmacol       Date:  1993-07       Impact factor: 8.739

Review 4.  Protein phosphorylation associated with the stimulation of neutrophils. Modulation of superoxide production by protein kinase C and calcium.

Authors:  P G Heyworth; J A Badwey
Journal:  J Bioenerg Biomembr       Date:  1990-02       Impact factor: 2.945

5.  Differential effects of G-protein activators on 5-hydroxytryptamine and platelet-derived growth factor release from streptolysin-O-permeabilized human platelets.

Authors:  P J Padfield; N Panesar; P Henderson; J J Baldassare
Journal:  Biochem J       Date:  1996-02-15       Impact factor: 3.857

6.  Regulation of sn-1,2-diacylglycerol second-messenger formation in thrombin-stimulated human platelets. Potentiation by protein kinase C inhibitors.

Authors:  W R Bishop; J August; J M Petrin; J K Pai
Journal:  Biochem J       Date:  1990-07-15       Impact factor: 3.857

7.  Phospholipase D activation is functionally linked to superoxide generation in the human neutrophil.

Authors:  R W Bonser; N T Thompson; R W Randall; L G Garland
Journal:  Biochem J       Date:  1989-12-01       Impact factor: 3.857

8.  Platelet phospholipase D is activated by protein kinase C via an integrin alpha IIb beta 3-independent mechanism.

Authors:  E A Martinson; S Scheible; A Greinacher; P Presek
Journal:  Biochem J       Date:  1995-09-01       Impact factor: 3.857

9.  Correlation between secretion and phospholipase D activation in differentiated HL60 cells.

Authors:  J Stutchfield; S Cockcroft
Journal:  Biochem J       Date:  1993-08-01       Impact factor: 3.857

10.  Vasopressin stimulates phospholipase D activity against phosphatidylcholine in vascular smooth muscle cells.

Authors:  C J Welsh; K Schmeichel; H T Cao; H Chabbott
Journal:  Lipids       Date:  1990-11       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.